Several years ago, we reviewed a paper suggesting that estrogen may be a beneficial treatment for women with schizophrenia. In this study, patients with schizophrenia were treated with estrogen. There was significant improvement in their [...]
The American College of Obstetrics and Gynecology now recommends that women be screened for depression during pregnancy. Because depressive symptoms during pregnancy have been associated with worse outcomes and are a robust predictor of postpartum [...]
Early observational studies suggested that postmenopausal hormone treatment may improve cognitive functioning in women; however, studies from the Women’s Health Initiative have shown that estrogen replacement therapy started in postmenopausal women (65 years or older) [...]
It is estimated that about 15% of women suffer from depression either during pregnancy or the postpartum period. Prior to the 1980s, most new mothers had never heard of postpartum depression. Over the last few [...]
Multiple studies have demonstrated that the postpartum period is a time of increased vulnerability in women with bipolar disorder. However, because many of the commonly used mood stabilizers carry some teratogenic risk, many women elect [...]
In 2006, Chambers and colleagues published an article linking selective serotonin reuptake inhibitor (SSRI) antidepressant use during late pregnancy to an increased risk of persistent pulmonary hypertension in the newborn (PPHN). PPHN is a cardiovascular [...]
An article published today in the US News and World Report discusses the expanded role pediatric health care providers are playing in screening new mothers for postpartum depression. Because pediatricians have frequent contacts with the mother [...]
